All In MedTech

Device Trial Radar · NCT05068011

Differential Target Multiplexed Spinal Cord Stimulation

Differential Target Multiplexed Spinal Cord Stimulation: a Multicenter Cohort Study

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Oct 6, 2021

Primary completion

Jan 2027

Study completion Jan 2027

Sponsor

Lead sponsor
Moens MaartenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 5, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluation of the effectiveness of differential target multiplexed spinal cord stimulation for treatment of chronic back and leg pain. Additionally, a subgroup analysis will be performed to evaluate potential differences between paddle/surgical leads versus percutaneous leads.

Conditions

  • Failed Back Surgery Syndrome
  • Persistent Spinal Pain Syndrome Type 2

Interventions

  • Spinal Cord StimulationDevice

    differential target multiplexed stimulation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall pain intensity with Visual Analogue Scale (VAS)Time frame: The change between the baseline screening and the evaluation 1 month after DTM stimulation, 6 months and 12 months

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • ZNA

    Antwerp, Belgium

  • AZ Sint-Jan Brugge-Oostende

    Bruges, Belgium

  • AZ Sint-Lucas Brugge

    Bruges, Belgium

11 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.